Ibuprofen for Postoperative Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if taking ibuprofen before a tooth extraction and bone graft reduces pain and improves oral health in the week following surgery. Participants will receive either ibuprofen, a common pain reliever, or a placebo, a sugar pill, one hour before their procedure to assess its impact on pain levels and quality of life. Suitable candidates for this trial are healthy individuals scheduled for a single tooth extraction with bone graft surgery who are not experiencing pain beforehand. As a Phase 4 trial, this research seeks to understand how the already FDA-approved ibuprofen benefits more patients, offering an opportunity to contribute to broader oral health improvements.
Will I have to stop taking my current medications?
The trial requires that you do not take certain medications, such as anti-inflammatory drugs, pain relievers, corticosteroids, or sedatives, for at least 4 weeks before participating. If you are on medications that affect wound healing or interact with NSAIDs, you may not be eligible to participate.
What is the safety track record for ibuprofen?
Research has shown that ibuprofen is generally safe and effective for managing post-surgical pain. Studies have found that doses of 200 mg and 400 mg can significantly relieve pain in many individuals with moderate to severe pain. Additionally, administering ibuprofen intravenously can effectively reduce pain and is less likely to cause nausea and vomiting.
Ibuprofen, a common pain reliever and anti-inflammatory medication, is widely used and considered safe when taken as directed. In this trial, participants will receive a 600 mg dose, which is typical. While all medications can have side effects, ibuprofen is generally safe for most people when used correctly. Always consult a healthcare provider to understand personal risks and benefits.12345Why are researchers enthusiastic about this study treatment?
Unlike the standard of care for postoperative pain, which often includes opioids with potential for addiction and side effects, ibuprofen offers a non-opioid alternative. Researchers are excited about ibuprofen because it targets inflammation directly and provides effective pain relief without the addiction risk associated with opioids. This makes it a safer option for managing pain after surgery, potentially reducing the need for stronger painkillers and minimizing side effects.
What is the effectiveness track record for ibuprofen in managing postoperative pain?
Research shows that ibuprofen helps reduce pain after surgery. Studies have found that even smaller doses, like 200 mg and 400 mg, significantly relieve pain for about half of the people with moderate to severe pain post-surgery. Strong evidence supports ibuprofen as a reliable choice for managing this type of pain, and many doctors and patients trust it for postoperative relief. In this trial, participants in the ibuprofen group will receive a 600 mg dose one hour before surgery to evaluate its effectiveness in managing postoperative pain.23678
Who Is on the Research Team?
Vrisiis Kofina, DDS, MS
Principal Investigator
Marquette University
Are You a Good Fit for This Trial?
This trial is for adults over 18 in good health who speak English and are scheduled for a single site tooth extraction and bone graft. It's not suitable for those with certain health conditions that aren't well-controlled.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive ibuprofen 600mg or placebo 1 hour prior to extraction and bone graft surgery
Postoperative Monitoring
Patient-reported pain and oral health-related quality of life are assessed using VAS and OHIP-14 over 7 days
Follow-up
Participants are monitored for safety and effectiveness after treatment, including clinical wound healing observations
What Are the Treatments Tested in This Trial?
Interventions
- Ibuprofen
Ibuprofen is already approved in United States, Canada, European Union, Japan, China, Switzerland for the following indications:
- Pain relief
- Fever reduction
- Inflammation
- Pain relief
- Fever reduction
- Inflammation
- Pain relief
- Fever reduction
- Inflammation
- Pain relief
- Fever reduction
- Inflammation
- Pain relief
- Fever reduction
- Inflammation
- Pain relief
- Fever reduction
- Inflammation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Marquette University
Lead Sponsor